Clinical Trial Update: Study of LTC004 Combine With Toripalimab in Patient With Solid Tumors Resistant to Immunotherapy [Phase 2]

View source ↗

Summary

An ongoing Phase 2 trial is evaluating LTC004 in combination with toripalimab for patients with advanced solid tumors resistant to immunotherapy, currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• LTC004 (LTC004)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Advanced Solid Tumor | Phase 2 | Status: RECRUITING